Parisa Lotfinejad
6PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 17, 2025
Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications.Erfan Rezazadeh-Gavgani, Reza Majidazar, Parisa Lotfinejad
|Sep 07, 2022
Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment.Seyed Ziaeddin Rasihashemi, Hadi Sahrai, Erfan Rezazadeh-Gavgani
|Nov 26, 2021
Tumor-derived exosomal PD-L1 in progression of cancer and immunotherapy.Seyed Z Rasihashemi, Erfan Rezazadeh Gavgani, Reza Majidazar
|Sep 28, 2020
COVID-19 Infection: Concise Review Based on the Immunological Perspective.Parisa Lotfinejad, Zahra Asadzadeh, Shiva Najjary
|Sep 22, 2020
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study.Parisa Lotfinejad, Mohammad Asghari Jafarabadi, Mahdi Abdoli Shadbad
|Jul 26, 2020
The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers.Omid Kooshkaki, Afshin Derakhshani, Hossein Safarpour
Pageof 1
Frequent Collaborators
3 joint publications
Behzad Baradaran
2 joint publications
Afshin Derakhshani
2 joint publications
Nicola Silvestris
1 joint publications
Omid Kooshkaki
1 joint publications
Hossein Safarpour
1 joint publications
Oronzo Brunetti
1 joint publications
Angelo Virgilio Paradiso
1 joint publications
Vito Racanelli
1 joint publications
Zahra Asadzadeh
1 joint publications
Shiva Najjary
